Systemic sclerosis (scleroderma): who works on it

One card per institution. Pick a target or a country to narrow the list.

• All targets
• CD19 47
• BCMA 25
• CD20 5
• JAK 0
• STAT3 0
• mTOR 0
• PPAR 0
• PD-1 1
• STING 0
• IL-17 0
• IL-6 0
• NLRP3 0
• CTLA-4 1
• CXCR4 0
• HMGB1 0
• IL-13 0
• IL-4 0
• NRF2 0
• PD-L1 1
• RUNX1 0
• SGLT2 0
• AKT 0
• CD123 0
• CD30 0
• CD38 1
• FGFR 0
• G6PD 0
• GLP-1 0
• HIF-1 0
• IL-15 1
• MMP-9 0
• PARP 0
• PI3K 0
• SIRT1 0
• TLR4 0
• TNF 0
• TP53 0
• TREM2 0
• TYK2 0

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

No running funded project names this disease yet.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Trials whose registry record says individual participant data (IPD) will be shared.

• Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Disease Patients

  NCT07249060· Hospital Universitario Araba· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 10
• Mendelian Randomization Analysis 8
• Gene Expression Profiling 14
• Sequence Analysis, RNA 3
• Exome Sequencing 1
• Proteomics 11
• Metabolomics 6
• Mass Spectrometry 2
• Flow Cytometry 9
• Immunohistochemistry 2
• Positron-Emission Tomography 3
• Magnetic Resonance Imaging 26
• Machine Learning 7
• Deep Learning 3
• Cohort Studies 42
• Genome-Wide Association Study 13

• Validation of a Novel, Low-Cost, Portable MRI-Compatible Exercise Device in Healthy Volunteers and Patients With Pulmonary Hypertension.

  NMR Biomed, Nov 2026

• Neurological involvement in localized scleroderma: a systematic review of clinical manifestations and neuroimaging findings.

  Front Immunol, Sept 2026

• Advances in imaging for systemic sclerosis.

  Rheumatology (Oxford), Sept 2026

• Advanced imaging in systemic sclerosis: distinguishing activity from damage across organ systems.

  Curr Opin Rheumatol, Aug 2026

• Scleroderma Renal Crisis and Posterior Reversible Encephalopathy Syndrome Triggered by Non-steroidal Anti-inflammatory Drugs.

  Intern Med, Aug 2026

• Orbital Involvement in Linear Scleroderma: A Review of The Literature With an Unusual Case.

  Ophthalmic Plast Reconstr Surg, Jul 2026

• Imaging techniques for assessing the hand in systemic sclerosis: a systematic review.

  Semin Arthritis Rheum, Jun 2026

• Retiform purpura and blue toe: an unusual presentation of systemic lupus erythematosus.

  Clin Rheumatol, Jun 2026

• Fibrosing myopathy in systemic sclerosis: Treatment response and clinical outcomes in a distinct subset.

  Semin Arthritis Rheum, Jun 2026

• Primary heart involvement assessed by cardiac magnetic resonance is associated with capillaroscopy abnormalities in systemic sclerosis.

  Adv Rheumatol, Jun 2026

See which targets of this disease your abstract mentions, and go to the people working on them.